465 results
-
Tell us what guidance you need on information sharing
Information governance is all about how to manage and share information appropriately. Many organisations have published guidance on information sharing in health and care, including guidance on how to use and share information to support the care of individuals, as well as for planning and research. NHSX - a new joint unit which is seeking to take forward digital transformation in the NHS - wants to bring all of this guidance together in one place, to simplify it, and to ensure that... MoreClosed 20 September 2019 -
Vonicog alfa for the treatment and prevention of bleeding in adults with von Willebrand disease
NHS England has launched a 30 day consultation on the use of vonicog alfa for the treatment and prevention of bleeding in adults with von Willebrand disease. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 18 September 2019 -
Dental services in Kent
We would like to hear your views on dental services in your area. We are hoping to put in place some new contracts to provide dental services in parts of the South East Kent so your feedback will be taken into account when doing this. Thank you for your time in sharing your views with us. MoreClosed 16 September 2019 -
Maternal intravenous immunoglobulin (IVIg) for the prevention of allo-immune fetal and neonatal haemochromatosis
NHS England has launched a 30 day consultation on a clinical policy proposition for maternal intravenous immunoglobulin (IVIg) for the prevention of allo-immune fetal and neonatal haemochromatosis. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 7 September 2019 -
Proton Beam Therapy for Children, Teenagers and Young Adults in the treatment of malignant and non-malignant tumours
NHS England has launched a six week consultation on a policy proposition for Proton Beam Therapy for Children, Teenagers and Young Adults in the treatment of malignant and non-malignant tumours. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 5 September 2019 -
Mercaptamine hydrochloride for corneal cystine deposits in people aged older than 2 years
NHS England has launched a 30 day consultation on the use of mercaptamine hydrochloride for corneal cystine deposits Related documents Policy Proposition Engagement Report Evidence Review Impact Assessment CPAG Summary Report MoreClosed 1 September 2019 -
Doravirine for the treatment of HIV 1 in adults
NHS England has launched a 30 day consultation on the use of doravirine for the treatment of HIV 1 in adults. Related documents Policy Proposition Engagement Report Evidence Review Impact Assessment CPAG Summary Report 1 CPAG Summary Report 2 MoreClosed 1 September 2019 -
Canakinumab for treating periodic fever syndromes: TRAPS, HIDS/MKD and FMF (ages 2 and older)
NHS England has launched a 30 day consultation on the use of canakinumab for treating periodic fever syndromes: tumour necrosis factor receptor associated periodic syndrome (TRAPS), hyperimmunoglobulin D syndrome/mevalonate kinase deficiency (HIDS/MKD) and familial Mediterranean fever (FMF). Related documents Policy Proposition Engagement Report Evidence Review Impact Assessment CPAG Summary Report MoreClosed 1 September 2019 -
Equality and Diversity in NHS Communications
As part of its on-going commitment to tackle equality and diversity issues, the London NHS Communications Network is inviting you to complete this survey. This survey aims to: Gather valuable insights from the NHS communications community that will inform what actions could be taken to address racial inequality and further promote equality in the NHS communications network. Gather a picture of who is currently working in our industry and what their roles entail. Reflect... MoreClosed 30 August 2019 -
Proposed changes to out of hours dental services in the West Midlands
This is a questionnaire in support of the c onsultation on proposed changes to ‘out of hours dental services in the West Midlands’. For full details of what is proposed please see the following: Needs Assessment (current services and future needs) Consultation Document (why we are consulting) Frequently asked questions Please note that these proposals do not affect existing in hours dental services provided through high street... MoreClosed 30 August 2019 -
Digital-first Primary Care: Policy consultation on patient registration, funding and contracting rules
All around us, a new generation of technology is changing our lives. Each year more of us choose online routes to book GP appointments, order repeat prescriptions or view personal health records. Digital innovations have the potential to support and empower patients, helping people to remain healthy and independent for longer. Used well, new technologies can also help to alleviate workload challenges in practices. The NHS Long Term Plan commits that every patient will... MoreClosed 23 August 2019 -
Ablative surgery, moulage technique brachytherapy and surgical reconstruction for head and neck soft tissue sarcoma in children and young people
NHS England has launched a 30 day consultation on a policy proposition for ablative surgery, moulage technique brachytherapy and surgical reconstruction for head and neck soft tissue sarcoma in children and young people. Related documents Policy proposition Evidence review Evidence report Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report MoreClosed 22 August 2019 -
Dexrazoxane for preventing cardiotoxicity in children and young people (< 25 years) receiving high-dose anthracyclines or related drugs for the treatment of cancer
NHS England has launched a 30 day consultation on a policy proposition for dexrazoxane for preventing cardiotoxicity in children and young people (< 25 years) receiving high-dose anthracyclines or related drugs for the treatment of cancer. Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report Clinical panel report CPAG summary report MoreClosed 22 August 2019 -
Idebenone for treating visual impairment in adults and young people with Leber's hereditary optic neuropathy
NHS England has launched a 30 day consultation on idebenone for treating visual impairment in adults and young people with Leber's hereditary optic neuropathy. Related documents Policy proposition Stakeholder engagement report Evidence review CPAG summary report Impact assessment report Clinical evidence evaluation MoreClosed 22 August 2019 -
Temozolomide as adjuvant treatment newly diagnosed anaplastic astrocytoma without 1p/19q codeletion following surgery and radiotherapy (adults)
Temozolomide is an oral medicine that works by stopping cancer cells from making deoxyribonucleic acid (DNA), thereby preventing cell growth. It is proposed to be an additional adjuvant treatment option for people with newly-diagnosed anaplastic astrocytoma who have already been treated with surgery and radiotherapy. NHS England has launched a 30 day consultation on a policy proposition on commissioning the use of temozolomide as adjuvant treatment for adults with newly diagnosed... MoreClosed 10 August 2019 -
Survey on NHS Domiciliary Dental Services in Derbyshire and Nottinghamshire
The contracts to provide domiciliary dental services in the Derbyshire and Nottinghamshire are due to expire at the end of March 2020. NHS England and NHS Improvement - Midlands is planning to commission new contracts to continue provision of this service and would like to ask patients and other service users who access this service to give their feedback on the current services, to ensure that the domiciliary dental service provision will meet the needs of the local population it serves. ... MoreClosed 6 August 2019 -
Children's Cancer Services
NHS England has launched a 60-day consultation to seek views on proposed changes to children's cancer services. These are used by children aged between 0 and 16. In some cases, and with the agreement of Teenage and Young Adult's Cancer Services, they may also treat teenagers up to the age of 18. The aim of the service specifications is to improve the outcomes and experience of children and young people with cancer. This consultation guide sets out: How care is currently... MoreClosed 4 August 2019 -
Teenager and Young Adults Cancer Services
NHS England has launched a 60-day consultation to seek views on proposed changes to teenager and young adult's cancer services. These are used by teenagers and young people aged between 16 up to the day before their 25th birthday. In some cases, and with the agreement of Children's Cancer Services, they may also treat teenagers from the age of 13. The aim of the service specifications is to improve the outcomes and experience of teenagers and young adults with cancer. This... MoreClosed 4 August 2019 -
Telotristat for treating carcinoid syndrome diarrhoea (Adults)
NHS England has launched a 2 month consultation on a policy proposition for telotristat for treating carcinoid syndrome diarrhoea (Adults). Related documents Policy proposition Evidence review Evidence report Impact assessment report Stakeholder engagement report CPAG summary report MoreClosed 30 July 2019 -
Consultation on proposed changes to ‘The transfer and remission of adult prisoners under the Mental Health Act 1983 good practice guidance 2019’ and introduction of ‘The transfer and remission of immigration removal centre detainees under the Mental Health Act 1983 good practice guidance 2019’
Publishing approval reference: 000647 NHS England and NHS Improvement have launched a national consultation on guidance relating to individuals held within prisons and immigration removal centres (IRCs) who have been detained under the Mental Health Act for assessment and treatment within mental health in-patient services. The consultation focuses on two proposed documents, which set out information and guidance on the transfer of these individuals to mental health in-patient... MoreClosed 19 July 2019 -
Addition of Rituximab to firstline standard chemotherapy for CD20 positive B-cell precursor Acute Lymphoblastic Leukaemia (adults)
NHS England has launched a 6 week consultation on a policy proposition for addition of Rituximab to firstline standard chemotherapy for CD20 positive B-cell precursor Acute Lymphoblastic Leukaemia (adults). Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report Clinical panel report MoreClosed 12 July 2019 -
Survey on GP services at Mevagissey Surgery
As joint commissioners, NHS England and NHS Improvement and NHS Kernow Clinical Commissioning Group are looking at alternative options for patients of Mevagissey Surgery. We are asking for valuable feedback from patients to understand how this could affect you and what impacts there may be in terms of accessibility, travel and range of services provided. Please answer as many questions as you can, as the more information we can collect, the better our... MoreClosed 5 June 2019 -
Help us shape the NHS England Midlands and East regional website
NHS Midlands and East of England would like to know more about how you use our regional website: www.england.nhs.uk/mids-east/ . We will use the information you provide to make sure our two regional websites meet the needs of all our visitors. This short survey will take no longer than five minutes to complete. You can save and exit the questionnaire at any time. You can be assured that NHS England will not use the information you provide for any other purpose than user... MoreClosed 31 May 2019 -
Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages)
NHS England has launched a 30 day consultation on Emicizumab as prophylaxis in people with severe congenital haemophilia A without factor VIII inhibitors (all ages). Haemophilia A is a rare condition that affects the blood's ability to clot. It is usually inherited and usually occurs in males. Emicizumab is a drug used to prevent bleeding or reduce the number of bleeds in people with haemophilia A. Emicizumab works by mimicking the action of factor VIII. Emicizumab binds to factor X... MoreClosed 12 May 2019 -
Implementing the NHS Long Term Plan - Proposals for possible changes to legislation
We are inviting patients, NHS staff, partner organisations and interested members of the public to give us your views on potential proposals for changing current primary legislation relating to the NHS. It’s possible to implement the NHS Long Term Plan without primary legislation. But legislative change could make implementation easier and faster. Local NHS bodies need to be free to work together with partners, including local authorities, to plan and provide care around... MoreClosed 25 April 2019 -
Lung volume reduction, policy proposition
NHS England has completed a 30 day consultation on a policy proposition on lung volume reduction. This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Stakeholder engagement report CPAG summary report Clinical panel report 1 Clinical panel report 2 Impact assessment report Evidence report Evidence review: LVR... MoreClosed 27 March 2019 -
Percutaneous mitral valve leaflet repair for mitral regurgitation
NHS England has completed a 30 day consultation on a policy proposition on percutaneous mitral valve leaflet repair for mitral regurgitation. This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical panel report ... MoreClosed 27 March 2019 -
Bictegravir / emtricitabine / tenofovir alafenamide for HIV
NHS England has completed a 30 day consultation on a policy proposition for HIV-1; bictegravir / emtricitabine / tenofovir alafenamide (B/F/TAF). This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report Clinical panel report MoreClosed 27 March 2019 -
Percutaenous patent foramen ovale closure for prevention of recurrent cerebral embolic stroke
NHS England has completed a 30 day consultation on a policy proposition on percutaenous patent foramen ovale closure for prevention of recurrent cerebral embolic stroke. This consultation ran from 25 February to 27 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review Impact assessment report Stakeholder engagement report CPAG summary report Clinical... MoreClosed 27 March 2019 -
Cholic acid in combination with chenodeoxyholic acid for inborn errors for bile synthesis
NHS England has completed a 30 day consultation on a policy proposition on cholic acid and chenodeoxycholic acid for treating inborn errors of bile acid synthesis. This consultation ran from 22 February to 24 March. A link to the consultation report and revised policy documents can be found below . Related documents Policy proposition Evidence review 1 Evidence review 2 Evidence review 3 Impact assessment report Stakeholder engagement... MoreClosed 24 March 2019
465 results.
Page 7 of 16